This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA approval, Bayer's extended Eylea intervals endorsement, and COVID shot variant targeting recommendations.

Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace transformation. In partnership with OpenAI, Moderna has created thousands of customized AI models in order to replicate work previously done by human employees.

In 2023, the federal Biomedical Advanced Research and Development Authority, part of HHS, requested proposals from Moderna and other companies to develop mRNA vaccines for potential public health ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

The U.S. government is giving drugmaker Moderna $176 million to ... in dairy cows across the country. The vaccine is in the early stages of development and would not be available until at least ...

Kennedy Jr, could imperil the development of this and other ... that the mRNA covid-19 vaccine was the “deadliest vaccine ever made.” Moderna stated last week it doesn’t expect its mRNA ...

Jan 17 (Reuters) - The U.S. government has awarded Moderna (MRNA.O), opens new tab $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle ...